baber/WOPTO huggingface dataset:
Patent CA-2373949-A1 (CA)
Title: Platform auger torque sensing brake activation
Inventor: JENSEN RODERICK JAMES
IPC: A01D41/127
Filed: 2002-02-28
Abstract: A harvesting assembly is provided with a transverse feed auger for directing harvested crop material into a feederhouse. The feed auger is also provided with retractable fingers. The retractable fingers are freely rotatably mounted on a finger timing shaft located in the feed auger. A feed auger torque sensor is mounted to the feed auger and communicates an actual feed auger torque signal to a controller. The controller is provided with a memory having a maximum desired feed auger torque signal. When the actual feed auger torque signal exceeds the maximum desired feed auger torque signal, the feed auger drive is disengaged. A timing shaft torque sensor is mounted to the finger timing shaft and communicates an actual timing shaft torque signal to the controller. The memory of the controller is provided with a maximum desired timing shaft torque signal. When the actual timing shaft torque signal exceeds the maximum desired timing shaft torque signal a brake is applied to the feed auger.
Patent CA-2374619-A1 (CA)
Title: Method for nonvolatile storage of at least one operating data value of an electrical motor and electrical motor for said method
Inventor: HORNBERGER JORG
IPC: H02P6/34
Filed: 2000-05-16
Abstract: The invention relates to a method for nonvolatile storage of an operating data value of an electrical motor (32) comprising a microprocessor or microcontroller (23) controlling the commutation thereof, in addition to a nonvolatile storage (74). According to said method, an old operating data value is transmitted from the nonvolatile storage (74) into a volatile storage (97) assigned to the microprocessor (23) when the motor (32) is turned on and stored in said storage as a variable. The variable is updated by the microprocessor in the time intervals in-between commutation processes (Fig. 13). The operating data value stored in the nonvolatile storage (74) is replaced at time intervals by the updated operating data value in line with the current value of the variable.      The invention also relates to a motor for implementing said method.
Patent CA-2376495-A1 (CA)
Inventor: HARLING JOHN DAVID
IPC: A61K31/00
Filed: 2000-06-29
Abstract: Compounds of formula (I) wherein Q is a monocyclic or bicyclic aryl or heteroaryl ring; R1 is hydrogen; R2 is hydrogen or up to three substituents selected from halogen, NO2, CN, N3, CF3O-, CF3S-, CF3SO2-, CF3CO-, C1-6alkyl, C1-6alkenyl, C1-6alkynyl, C1-6perfluoroalkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl-, C1-6alkylO-C1-6alkylCO-, C3-6cycloalkylO-, C3-6cycloalkylCO-, C3-6cycloalkyl-C1-4alkylO-, C3-6cycloalkyl-C1-4alkylCO-, phenyl, phenoxy, benzyloxy, benzoyl, phenyl-C1-4alkyl-, C1-6alkylS-, C1-6alkylSO2-, (C1-4alkyl)2NSO2-,(C1-4alkyl)NHSO2-, (C1-4alkyl)2NCO-, (C1-4alkyl)NHCO-, or CONH2, or -NR3R4 where R3 is hydrogen or C1-4alkyl, and R4 is hydrogen, C1-4alkyl, formyl, -CO2C1-4alkyl, or -COC1-4alkyl, or two R2 groups together form a carbocyclic ring that is saturated or unsaturated and unsubstituted or substituted by -OH or =O; X is halogen, C1-6 alkoxy, C1-6 alkyl, or C1-6 perfluoroalkyl, and; Y is hydrogen, halogen, C1-6 alkoxy, C1-6 alkyl, or C1-6 perfluoroalkyl; but excluding the compounds N-(5-Iodo-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-azidobenzamide and N-(5-iodo-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-benzoyl-2-methoxybenzamide; and pharmaceutically acceptable salts or solvates thereof possess anticonvulsant activity and are useful in the treatment of a variety of disorders.
Patent CA-2382704-A1 (CA)
Title: Dispositif de voirie a couvercle articule
Inventor: HAUER JEAN-CLAUDE
IPC: E02D29/14
Filed: 2001-06-18
Abstract: Pour sécuriser contre le vol un couvercle (3) rigide monté articulé sur un châssis (1) et comprenant deux bords latéraux (32A, 32B) portant deux tourillons (30A, 30B) définissant un axe d'articulartion parallèle à une riv e d'articulation (31) du couvercle et venant s'engager dans deux alvéoles (10)  du châssis surplombées au moins partiellement par une paroi (13) de ce châssis, ce couvercle comporte un doigt (36) élastique s'étendant parallèlement aux bords latéraux (32A, 32B); l'extrémité libre du doigt est situées à proximité de la rive d'articulation (31) et coopère avec un ergot de poussée (14) porté par le bord d'articulation (11) correspondant du châssis pour permettre, par déformation élastique du doigt (36) en appui contre l'ergot (14), la mise en place des tourillons (30A, 30B) dans leurs alvéoles  (10) respectives et leur retrait. Utilisation: recouvrement des cheminées de s réseaux d'eau souterrains.
Patent CA-2386319-A1 (CA)
Title: System for setting transmission protocol based on detected baud rate
Inventor: HAYS PAUL J
IPC: H04L29/08
Filed: 2000-10-10
Abstract: A system for setting baud rate and communication protocol in a remote device. In this invention, the remote device (301) receives samples of signals from a host device in a buffer. The remote device then (303) detects a baud rate of the signals from the samples. A protocol being used by the host device to communicate is also (304) determined from the samples. The remote device is then (305) set to communicate using the determined protocol at the detected baud rate.
Patent CA-2387785-A1 (CA)
Title: Human transferase molecules
Inventor: HILLMAN JENNIFER L
IPC: A61P19/02
Filed: 2000-11-02
Abstract: The invention provides human transferase molecules (HTFS) and polynucleotide s which identify and encode HTFS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention al so provides methods for diagnosing, treating, or preventing disorders associate d with expression of HTFS.
Patent CA-2390296-A1 (CA)
Title: Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
Inventor: GIESINGER BRIGITTE
IPC: C07D295/12
Filed: 2000-11-06
Abstract: A process is provided for producing a compound having the formula:  (see formula 1.0) by: (a) reacting a compound having the formula (see formula 2.) with a compound having the formula (see formula 3.0) in the presence of an organic base selected from the group consisting of:  triethylamine;  N,N-diisopropylethylamine; 1,8-diazabicyclo[5.4.0]undec-7-ene (1,5-5); 1,5-diazabicyclo[4.3.0]non-5-ene; and 1,4-diazabicyclo[2.2.2]octane to form a compound having the formula (see formula 4.0) (b) reducing the compound of formula (4.0) to form the compound of formula (1.0), wherein X is Cl, Br, I or F.
Patent CA-2392449-A1 (CA)
Title: Lockset mechanism having a semi-permanent mechanical connection
Inventor: ARMSTRONG STEVEN
IPC: E05B3/06
Filed: 2000-11-22
Abstract: The present invention provides a lockset mechanism (20) having a semi-permanent mechanical connection between the interior and exterior components thereof. The lockset mechanism (20) includes an exterior cylinder assembly (22) releasably coupled to a mounting plate (24), an interior cylinder assembly (26) having a locking blade (60) interdisposed between the mounting plate (24) and the interior cylinder assembly (26) for providing a semi-permanent mechanical connection. The locking blade (60) is rotatably positionable from an unlocked position wherein the interior cylinder assembly (26) is uncoupled from the mounting plate (24) to a locked position wherein the interior cylinder assembly (26) is coupled to the mounting plate (24) upon rotation of a knob assembly (58).
Patent CA-2392453-A1 (CA)
Inventor: GRAUPNER GERHART
IPC: C07K14/47
Filed: 2000-11-22
Abstract: Selon l'invention, un polypeptide est identifié comme étant fonctionnellement compris dans une voie de transduction du signal présentant un effet biologique. Ces polypeptides sont différents du récepteur d'acide rétinoïque, du récepteur de rétinoïde X, ou d'une protéine de liaison d'acide rétinoïque cellulaire, cependant, la liaison du rétinoïde ou du métabolite rétinoïde module l'effet biologique. Dans des procédés de la présente invention, un rétinoïde ou un métabolite rétinoïde est administré à une cellule ou à un mammifère en concentration suffisante à moduler cet effet biologique.
Patent CA-2395265-A1 (CA)
Inventor: GOLZENLEUCHTER THOMAS
IPC: C09K13/06
Filed: 2000-12-07
Abstract: La présente invention concerne un nouveau procédé de réalisation de surfaces structurées sur des surfaces de silicium polycristallin, tricristallin et monocristallin de piles solaires, ou sur des substrats de silicium qui sont utilisés pour exploiter l'effet photovoltaïque. L'invention concerne en particulier un procédé d'attaque et un produit d'attaque pour la réalisation d'une surface structurée sur un substrat de silicium.
Patent CA-2395336-A1 (CA)
Title: Methods and compositions for producing artificial fascia
Inventor: ATALA ANTHONY
IPC: A61L27/38
Filed: 2000-12-14
Abstract: The present invention describes methods for producing artificial fascial slings and their subsequent use in treating subjects with urinary incontinence. The invention is based, in part, on the discovery that mesenchymal cells that secrete elastin and collagen, extracellular proteins responsible for elasticity and strength, respectively, can be used to engineer artificial fascia in vitro.
Patent CA-2396186-A1 (CA)
Inventor: HAREL AVIKAM
IPC: A61Q19/08
Filed: 2001-01-09
Abstract: La présente invention concerne des compositions pharmaceutiques destinées au traitement des maladies hyperprolifératives de l'épiderme telles que les cancers et le psoriasis, ainsi qu'au traitement du vieillissement de l'épiderme. Le principe actif peut être du nicotinamide (NA), de l'adénosine diphosphate-ribose cyclique (cADPR), ou une association des deux.
Patent CA-2398164-A1 (CA)
Inventor: ARAI KOJI
IPC: A63F13/49
Filed: 1996-12-12
Abstract: Disclosed is a method of executing a television game having one character operated by a player and another character, which comprises backing up a first state of progress of the game at a first time, the first state of progress including a first state of one character and a first state of another character; backing up a second state of progress of the game at a second time after the first time, wherein the second state of progress includes a second state of one character and a second state of another character; and restarting the progress of the game from the first time so that one character has the first state backed up at the first time and another character has the second state backed up at the second time. A game cartridge for insertion into a main body of a television game machine for executing a television game having one character operated by a player and another character is also disclosed.
Patent CA-2398433-A1 (CA)
Inventor: LINDAU LEIF
IPC: B01D46/02
Filed: 2001-01-31
Abstract: When cleaning a barrier filter, comprising a plurality of filter elements, of woven fabric of felt, arranged to separate particles out of a polluted gas, the filter elements are cleaned, separately or in groups, by pressurised air pulses, the frequency, the maximum pressure and the duration of which are varied in order to minimise, by an adjustment, the total emission of dust. The frequency and/or the maximum pressure and/or the duration of the cleaning pulses are varied for a group or a plurality of groups of filter elements. After each cleaning pulse, the maximum value for the instantaneous emission of dust, the emission peak, is determined and the emission peak is used, after cleaning a certain group of filter elements, for selecting the frequency and/or the maximum pressure and/or the duration of the cleaning pulses for this group of filter elements during continued operation.
Patent CA-2400367-A1 (CA)
Title: Reduction of in planta degradation of recombinant plant products
Inventor: STEVENS LUCAS HENRICUS
IPC: A01H5/00
Filed: 2001-02-15
Abstract: The invention relates to the field of the production and harvesting of plant  products produced by biosynthesis in transgenic plants. The invention provid es a method to increase the level of a desired product obtainable from a recombinant plant comprising allowing said plant to synthesise said product further comprising at least partly preventing degradation of said product.</ SDOAB>
Patent CA-2400565-A1 (CA)
Inventor: BILLOTTE ANNE
IPC: A61K9/48
Filed: 2002-08-30
Abstract: The present invention is concerned with means for adjusting the bioavailability of atorvastatin calcium by modulating its rate of release from multiparticulate formulations and with multiparticulate formulations, especially tablets and capsules, having said modulated rate of release.
Patent CA-2401561-A1 (CA)
Title: Tableau effacable
Inventor: DONELAN JAMES P
IPC: G09F9/00
Filed: 2000-02-28
Abstract: L'invention concerne un tableau effaçable composé d'un substrat (11a) située sous un film transparent (12a). On écrit sur ce film transparent (12a) à l'aide de marqueurs à essuyage à sec. Des graphiques peuvent être placés directement sur le substrat (11a) ou une couche intermédiaire (16) peut être placée entre le film transparent (12a) et le substrat (11a). La couche intermédiaire (16) peut servir de support à des graphiques, à des motifs ou à d'autres éléments pouvant être imprimés sur la couche intermédiaire (16) de façon manuelle ou informatique. Cette couche intermédiaire (16) peut être remplacée facilement et avantageusement par une autre couche intermédiaire (16) possédant un autre motif imprimé.
Patent CA-2408197-A1 (CA)
Title: Procede de fabrication d'une gaine de cable par extrusion et reticulation d'une composition a base de polymere greffe silane, et cable comportant une gaine obtenue par ce procede
Inventor: BARIOZ CHANTAL
IPC: C08F255/06
Filed: 2002-10-17
Abstract: La présente invention concerne un procédé de fabrication d'une gaine de câb le par extrusion et réticulation d'une composition à base d'un polymère greffé silane comprenant les étapes suivantes:  a) mélange des composés suivants:  i. un polymère de base thermoplastique ou un mélange de polymères de base thermoplastiques  ii. un premier composé à base de silane  iii. un générateur de radicaux libres  b) extrusion dudit mélange sur un câble pour obtenir ladite gaine  c) réticulation de ladite gaine.  Ce procédé se caractérise par le fait que l'on incorpore au cours du mélange  un composé contenant une fonction amine secondaire, et en ce que la réticulatio n est effectuée à l'atmosphère ambiante.
Patent CA-2408719-A1 (CA)
Inventor: LLANOS GERARD H
IPC: A61F2/06
Filed: 2001-05-14
Abstract: A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.
Patent CA-2408925-A1 (CA)
Inventor: WISNIEWSKI THOMAS
IPC: C07K19/00
Filed: 2001-05-22
Abstract: L'invention concerne des peptides immunogènes synthétiques mais non-amyloïdogènes homologues de bêta-amyloïde, qui peuvent être utilisés seuls ou en conjugaison avec une molécule immunostimulatrice dans une composition d'immunisation visant à induire une réaction immunitaire contre les peptides bêta-amyloïdes et les dépôts bêta-amyloïdes.
Patent CA-2410317-A1 (CA)
Title: Methods for assaying gene imprinting and methylated cpg islands
Inventor: JIANG SHAN
IPC: C12Q1/68
Filed: 2001-05-22
Abstract: Provided is a method for isolating methylated CpG islands. The method includes identifying an imprinted gene adjacent to the methylated CpG island, and identifying a disease which is preferentially transmitted by one parent and which is genetically linked to region of genomic DNA which contains the imprinted gene, whereby the imprinted gene is thereby indicated as a candidate gene involved in transmitting the disease.
Patent CA-2412860-A1 (CA)
Inventor: RORVICK ANTHONY W
IPC: A61N1/375
Filed: 2001-06-27
Abstract: Flat electrolytic capacitors, particularly, for use in implantable medical devices (IMDs), and the methods of fabrication of same are disclosed. The capacitors are formed with an electrode stack assembly comprising a pluralit y of stacked capacitor layers each comprising an anode sub-assembly of at leas t one anode layer, a cathode layer and separator layers wherein the anode and cathode layers have differing dimensions that avoid electrical short circuit s between peripheral edges of adjacent anode and cathode layers but maximize anode electrode surface area. The electrolytic capacitor is formed of a capacitor case defining an interior case chamber and case chamber periphery,  an electrode stack assembly of a plurality of stacked capacitor layers havin g anode and cathode tabs disposed in the interior case chamber, an electrical connector assembly for providing electrical connection with the anode and cathode tabs through the case, a cover, and electrolyte filling the remainin g space within the interior case chamber. The plurality of capacitor layers an d further separator layers are stacked into the electrode stack assembly and disposed within the interior case chamber such that the adjacent anode and cathode layers are electrically isolated form one another. The anode layer peripheral edges of the anode sub-assemblies of the stacked capacitor layers  extend closer to the case side wall than the cathode peripheral edges of the  cathode layers of the stack of capacitor layers throughout a major portion o f the case chamber periphery. The separator layer peripheral edges extend to t he case periphery and space the anode layer peripheral edges therefrom. Any burrs, debris or distortions along or of any of the anode layer peripheral edges causing the anode layer edges to effectively extend in the electrode stack height direction causes the anode layer peripheral edges having such tendency to contact an adjacent anode layer. In this way, anode layer surfac e area is maximized, and short circuiting of the anode layers with the cathode  layers is avoided. A case liner can also be disposed around the electrode stack assembly periphery.
Patent CA-2417646-A1 (CA)
Inventor: DOW GORDON J
IPC: A61K47/10
Filed: 2001-07-24
Abstract: A topical aqueous gel composition is provided that has a viscosity of less than about 15,000 cP and a pH of about 3.0 to 9.0 for treating a skin disorder in a human subject. The composition consists essentially of (a) a therapeutically-effective amount of at least one compound useful for treating such a disorder, (b) a hydrophilic pharmaceutically-acceptable, polymer material such as a lightly cross-linked polyacrylic acid polymer compatible with the compound, (c) a pharmaceutically-acceptable base to adjust pH, (d) optionally a water miscible solvent, (e) optionally a preservative, (f) water, and (g) optionally an oil phase component and a suitable surfactant. The composition is useful for treating an inflammatory skin disorder, acne, or rosacea. The low viscosity composition has an advantage of being administered more accurately when combined with a container that administers the composition as drops.
Patent CA-2418017-A1 (CA)
Title: Weight holder device for weight lifting apparatus
Inventor: ROY NORMAND
IPC: A63B21/072
Filed: 2003-02-06
Abstract: A weight holder device for use in combination with a weight lifting exercise apparatus that includes a stack of several plates of equal size and weight and each having a vertical central through hole to receive a vertical lifting rod with a horizontal through bore and a horizontal hole extending from the central hole to a side of the plate. The device includes a shear pin removably inserted through both the horizontal hole and the through bore and supporting a variable number of upper plates of the stack. A protruding end of the pin has an axially adjustable holder mounted thereon for releasably and tightly suspending a fractional weight therefrom, between two spaced flanges secured to and radially extending from the pin. At least one of the flanges has a locking member and is axially adjustable relative to the other flange and along the pin to releasably engage and tightly retain the weight between them via the locking member in unlocking and locking configuration respectively.
Patent CA-2418571-A1 (CA)
Title: An expandable envelope construction
Inventor: MAKOFSKY MARVIN A
IPC: B65D5/355
Filed: 2003-02-05
Abstract: A single blank is used to make an expandable envelope construction having four side edges which can expand as the envelope construction is filled to capacity. The blank is provided with horizontal and vertical score lines and fold lines which permit the sides and bottom of the construction to collapse inwardly while the pocket enlarges in thickness and decreases in height and width. The blank has side flaps with corners at the ends which are overlaid by the back panel and closure panel in an unsecured manner to maintain the envelope in a sealed condition when expanded.
Patent CA-2420149-A1 (CA)
Title: Dry powder formulation for protein labeling
Inventor: OLECH LEE
IPC: G01N33/543
Filed: 2001-08-03
Abstract: The proteins in a biological sample that is sought to be analyzed for its protein composition by a chromatographic procedure are coupled to a dye in an unusually efficient manner by combining the sample with a dry powdered mixture containing the dye, a buffering agent, and in preferred embodiments, a denaturing agent as well. The dry powdered form of the mixture avoids deterioration or decomposition of the dye, and the combination of components in the mixture allows the dye to couple to the proteins in a relatively uniform and highly controllable manner when the powder mixture and sample are heated together and held at an elevated temperature until some or all of the powder dissolves.
Patent CA-2422320-A1 (CA)
Title: Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
Inventor: DESPREZ PIERRE-YVES
IPC: C12Q1/68
Filed: 2001-09-14
Abstract: A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of brea st tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2  gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
Patent CA-2422781-A1 (CA)
Inventor: DUTORDOIR CHRISTOPHE
IPC: G06Q10/00
Filed: 2001-09-19
Abstract: L'invention consiste en l'insertion dans un message électronique de type appropié (par exemple format HTLM ou XML) d'un code générant automatiquement  une requête sur un réseau de communication lors de l'affichage dudit message  par son destinataire. La requête consiste en l'appel sur un serveur défini d'un fichier au nom unique, ou d'une page (URL) passant en paramètre un code  unique. Ce nom de fichier ou ce code unique correspondant à un enregistremen t préalablement crée. Le système peut alors sélectionner cet enregistrement et  envoyer à son créateur affiché par le destinataire.
Patent CA-2424382-A1 (CA)
Title: Penetrator arrow projectile
Inventor: FOSSUMSTUEN KAI
IPC: F42B10/40
Filed: 2001-09-28
Abstract: A penetrator arrow projectile for launching by use of a launcher projectile which comprises a propellant charge and which may be separated from the arrow projectile in the trajectory. A "base-bleed" charge (2) is situated rearwardmost on the arrow projectile (1), in order to be ignited by means of an igniter device (3) in connection with the separation from the launcher projectile, which may comprise a forward igniter device for igniting the "base-bleed" charge (2). The launcher projectile may also comprise a mechanism for retaining the arrow projectile (1) on the forward end and for releasing the arrow projectile in the trajectory.